Table 2.

Time taken to reach simulation endpoints in each dosing regimen and each endogenous immunoglobulin (Ig)G level group

End-point	Endogenous IgG level	Regimen 3	Regimen 4	Regimen 5	Regimen 6
Time to IgG 7 g/l, weeks	4 g/l	10	2* (6)	2* (6)	<1
	1·5 g/l	24	21	21	2
Time to 90% of steady state, weeks	4 g/l	13	2* (9)	2* (9)	<1
	1·5 g/l	21	17	16	2

^*IgG level transiently dropped below the indicated level after the switch to maintenance dose (time to regain indicated level shown in brackets).